Comprehensive Stock Comparison
Compare Sachem Capital Corp. 6.00% Note (SCCE) vs Welltower Inc. (WELL) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | WELL | 38.0% revenue growth vs SCCE's -107.0% |
| Value | WELL | Better valuation composite |
| Quality / Margins | WELL | 8.6% net margin vs SCCE's -292.1% |
| Stability / Safety | SCCE | Beta 0.01 vs WELL's 0.29 |
| Dividends | SCCE | 1.5% yield; WELL pays no meaningful dividend |
| Momentum (1Y) | WELL | +36.8% vs SCCE's +33.4% |
| Efficiency (ROA) | WELL | 1.4% ROA vs SCCE's -6.9%, ROIC 0.9% vs -13.0% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Sachem Capital Corp. is a real estate finance company that originates short-term, secured loans to real estate investors for property acquisition and development. It makes money primarily through interest income from its loan portfolio — earning interest on loans secured by first mortgage liens on residential and commercial properties. The company's competitive advantage lies in its specialized focus on short-term real estate lending and its ability to provide quick financing solutions to investors who may not qualify for traditional bank loans.
Welltower is a healthcare-focused real estate investment trust that owns and invests in seniors housing communities, post-acute care facilities, and outpatient medical properties. It generates revenue primarily through rental income from its healthcare real estate portfolio — with seniors housing contributing roughly 60% of net operating income, outpatient medical properties about 25%, and post-acute care facilities the remainder. The company's competitive advantage lies in its scale and strategic partnerships with leading healthcare operators, creating a diversified portfolio concentrated in high-growth markets across the U.S., Canada, and the U.K.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
WELL leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). SCCE leads in 1 (Risk & Volatility). 1 tied.
Financial Metrics (TTM)
WELL is the larger business by revenue, generating $10.8B annually — 946.1x SCCE's $11M. WELL is the more profitable business, keeping 8.6% of every revenue dollar as net income compared to SCCE's -2.9%. On growth, SCCE holds the edge at +82.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SCCESachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| RevenueTrailing 12 months | $11M | $10.8B |
| EBITDAEarnings before interest/tax | -$12M | $2.6B |
| Net IncomeAfter-tax profit | -$33M | $934M |
| Free Cash FlowCash after capex | $5M | $2.1B |
| Gross MarginGross profit ÷ Revenue | -4.8% | +20.9% |
| Operating MarginEBIT ÷ Revenue | -108.1% | +4.9% |
| Net MarginNet income ÷ Revenue | -2.9% | +8.6% |
| FCF MarginFCF ÷ Revenue | +42.5% | +19.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +82.6% | +46.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +98.1% | -26.3% |
Valuation Metrics
| Metric | SCCESachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| Market CapShares × price | $1.1B | $144.3B |
| Enterprise ValueMkt cap + debt − cash | $206.0B | $142.0B |
| Trailing P/EPrice ÷ TTM EPS | -25.37x | 149.01x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 73.28x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 54.40x |
| Price / SalesMarket cap ÷ Revenue | — | 13.31x |
| Price / BookPrice ÷ Book value/share | 6.16x | 3.26x |
| Price / FCFMarket cap ÷ FCF | 86.47x | 50.06x |
Profitability & Efficiency
WELL delivers a 2.2% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-19 for SCCE. WELL carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to SCCE's 1127.83x. On the Piotroski fundamental quality scale (0–9), WELL scores 5/9 vs SCCE's 2/9, reflecting solid financial health.
| Metric | SCCESachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| ROE (TTM)Return on equity | -19.1% | +2.2% |
| ROA (TTM)Return on assets | -6.9% | +1.4% |
| ROICReturn on invested capital | -13.0% | +0.9% |
| ROCEReturn on capital employed | -31.8% | +0.9% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 |
| Debt / EquityFinancial leverage | 1127.83x | 0.07x |
| Net DebtTotal debt minus cash | $187M | -$2.2B |
| Cash & Equiv.Liquid assets | $18M | $5.0B |
| Total DebtShort + long-term debt | $204.9B | $2.8B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.81x |
Total Returns (with DRIP)
A $10,000 investment in WELL five years ago would be worth $32,119 today (with dividends reinvested), compared to $12,597 for SCCE. Over the past 12 months, WELL leads with a +36.8% total return vs SCCE's +33.4%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.6% vs SCCE's 12.7% — a key indicator of consistent wealth creation.
| Metric | SCCESachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| YTD ReturnYear-to-date | +1.7% | +11.2% |
| 1-Year ReturnPast 12 months | +33.4% | +36.8% |
| 3-Year ReturnCumulative with dividends | +43.0% | +190.2% |
| 5-Year ReturnCumulative with dividends | +26.0% | +221.2% |
| 10-Year ReturnCumulative with dividends | +26.0% | +270.5% |
| CAGR (3Y)Annualised 3-year return | +12.7% | +42.6% |
Risk & Volatility
SCCE is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than WELL's 0.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | SCCESachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.01x | 0.29x |
| 52-Week HighHighest price in past year | $23.95 | $215.56 |
| 52-Week LowLowest price in past year | $18.39 | $130.29 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 53.9 | 69.0 |
| Avg Volume (50D)Average daily shares traded | 3K | 2.5M |
Analyst Outlook
SCCE is the only dividend payer here at 1.48% yield — a key consideration for income-focused portfolios.
| Metric | SCCESachem Capital Co… | WELLWelltower Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $221.45 |
| # AnalystsCovering analysts | — | 34 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $0.35 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +100.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 22 | Feb 26 | Change |
|---|---|---|---|
| Sachem Capital Corp… (SCCE) | 100 | 94.63 | -5.4% |
| Welltower Inc. (WELL) | 100 | 191.61 | +91.6% |
Welltower Inc. (WELL) returned +221% over 5 years vs Sachem Capital Corp… (SCCE)'s +26%. A $10,000 investment in WELL 5 years ago would be worth $32,119 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sachem Capital Corp… (SCCE) | $10.2B | $-2.1B | -120.7% |
| Welltower Inc. (WELL) | $4.3B | $10.8B | +154.9% |
Welltower Inc.'s revenue grew from $4.3B (2016) to $10.8B (2025) — a 11.0% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sachem Capital Corp… (SCCE) | 60.9% | 18.8% | -69.1% |
| Welltower Inc. (WELL) | 25.4% | 8.6% | -65.9% |
Welltower Inc.'s net margin went from 25% (2016) to 9% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Welltower Inc. (WELL) | 50.6 | 133.5 | +163.8% |
Welltower Inc. has traded in a 27x–219x P/E range over 9 years; current trailing P/E is ~149x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Sachem Capital Corp… (SCCE) | 0.32 | -0.93 | -390.6% |
| Welltower Inc. (WELL) | 2.81 | 1.39 | -50.5% |
Welltower Inc.'s EPS grew from $2.81 (2016) to $1.39 (2025) — a -8% CAGR.
Chart 6Free Cash Flow — 5 Years
Sachem Capital Corp. 6.00% Note generated $13M FCF in 2024 (-100% vs 2021). Welltower Inc. generated $3B FCF in 2025 (+129% vs 2021).
SCCE vs WELL: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is SCCE or WELL a better buy right now?
Welltower Inc. (WELL) offers the better valuation at 149.0x trailing P/E (73.3x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SCCE or WELL?
Over the past 5 years, Welltower Inc. (WELL) delivered a total return of +221.2%, compared to +26.0% for Sachem Capital Corp. 6.00% Note (SCCE). A $10,000 investment in WELL five years ago would be worth approximately $32K today (assuming dividends reinvested). Over 10 years, the gap is even starker: WELL returned +270.5% versus SCCE's +26.0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SCCE or WELL?
By beta (market sensitivity over 5 years), Sachem Capital Corp. 6.00% Note (SCCE) is the lower-risk stock at 0.01β versus Welltower Inc.'s 0.29β — meaning WELL is approximately 4492% more volatile than SCCE relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 7% versus 1128% for Sachem Capital Corp. 6.00% Note — giving it more financial flexibility in a downturn.
04Which has better profit margins — SCCE or WELL?
Sachem Capital Corp. 6.00% Note (SCCE) is the more profitable company, earning 1879% net margin versus 8.6% for Welltower Inc. — meaning it keeps 1879% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SCCE leads at 844.1% versus 4.9% for WELL. At the gross margin level — before operating expenses — SCCE leads at 100.0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — SCCE or WELL?
In this comparison, SCCE (1.5% yield) pays a dividend. WELL does not pay a meaningful dividend and should not be held primarily for income.
06Is SCCE or WELL better for a retirement portfolio?
For long-horizon retirement investors, Sachem Capital Corp. 6.00% Note (SCCE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.01), 1.5% yield). Both have compounded well over 10 years (SCCE: +26.0%, WELL: +270.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between SCCE and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. SCCE pays a dividend while WELL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.